Portopulmonary Hypertension
PoPH is a well-recognized complication of portal hypertension with or without cirrhosis and is classified as a subset of PAH. Identification of PoPH is crucial as it has a major impact on prognosis and liver transplant candidacy. Echocardiogram is the initial screening tool of choice and the patient should proceed to RHC for confirmation. PAH-directed therapy is the treatment of choice, allowing the patient to achieve a hemodynamic threshold to undergo a liver transplant safely.
Source: Clinics in Liver Disease - Category: Gastroenterology Authors: Yu Kuang Lai, Paul Y. Kwo Source Type: research
More News: Cirrhosis | Gastroenterology | Hypertension | Liver | Liver Disease | Liver Transplant | Transplant Surgery | Transplants | Urology & Nephrology